Clinical inputs
Understand the result,
not just the number.
MRI-LGE Extent (% LV Mass Fibrosis): Comprehensive Explanation and Clinical Context This calculator estimates the proportion of myocardial fibrosis (late gadolinium enhancement, LGE) relative to total left ventricular (LV) mass using cardiac MRI data: %LGE = (LGE mass / LV mass) × 100. When input volumes are provided, they are converted to grams assuming a myocardial density of 1.05 g/mL. LGE reflects focal myocardial scar or fibrosis and is a powerful prognostic marker across cardiomyopathies.
In hypertrophic cardiomyopathy (HCM), the presence of extensive LGE (≥15% of LV mass) is a major risk modifier for sudden cardiac death, guiding ICD consideration. In ischemic heart disease, infarct size >30% LV mass predicts adverse remodeling and increased mortality, while smaller infarcts carry better prognosis. In dilated/non-ischemic cardiomyopathy (DCM/NICM), the presence (rather than exact % extent) of LGE, especially mid-wall, predicts arrhythmia and mortality, though standardized thresholds are lacking.
Overall, LGE quantification refines risk stratification and complements functional and clinical assessment in precision cardiology.
- Source 1
Ommen SR et al. AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy. Circulation. 2024;149:e331–e423. doi:10.1161/CIR.0000000000001250.
- Source 2
Wozniak M et al. How to assess sudden cardiac death risk in hypertrophic cardiomyopathy. Polish Heart Journal.
- Source 3
Gräni C et al. Extensive LGE and outcome prediction in HCM. JACC. 2020;75(3):274–286.
- Source 4
Kim RJ et al. Infarct quantification with cardiovascular magnetic resonance: methodology and clinical relevance. Circulation.
- Source 5
Assumptions for myocardial density: 1.05 g/mL (CMR Quantification Standards, SCMR, 2023).
- Source 6
Gulati A et al. Prognostic value of LGE in non-ischemic cardiomyopathy. JACC. 2013;61:895–904.
Loading discussion…